Skip to main content

Pre-Clinical

Pre-Clinical

Rho Bio: Harnessing the body's natural drain to cure disease

Machine-guided design of synthetic cell type-specific cis-regulatory elements for genetic therapies

First-in-class small molecules for cancer cachexia

Development of a New Class of Therapeutics to Treat Poisoning Diseases

Developing therapeutics for novel targets controlling oncogene amplification

Biotherapeutic for Systemic Sclerosis

Targeting RNA polymerase I for breast cancer therapy

Dual MIF - D-DT Targeting to Enhance Immunotherapy Responses

Novel Peptides for the Treatment of Peripheral Arterial Disease

Develop Vitamin D Receptor Agonists to Treat Obesity

Subscribe to Pre-Clinical